title: Author reply: To PMID 22584020.
authors: Nicolas
authors: N
authors: Molina-Prat
authors: Alejandro
authors: A
authors: Saint-Jean
authors: Maite
authors: M
authors: Sainz de la Maza
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D057112:Corneal Perforation / Q000139:chemically induced*; D004483:Ectropion / Q000139:chemically induced*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors